Development of Spray-Dried Powders for Pulmonary Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 125
Special Issue Editors
Interests: inhaled drug delivery; nanotechnology; natural/synthetic polymeric nanoparticles; lung delivery of anticancer drugs; nanoparticulate lung drug delivery against lower respiratory tract infections
Special Issues, Collections and Topics in MDPI journals
Interests: spray drying; particle engineering; co-amorphous systems; dry powder inhalation; pulmonary drug delivery; lung infections
Special Issue Information
Dear Colleagues,
Spray drying represents an attractive method for engineering inhaled drug particles. It enables the production of particles with well-controlled size, shape, and density which are crucial for the effectiveness of particles’ aerosolization and lung deposition. Spray drying is also widely utilized to improve the solubility of poorly water-soluble drugs, produce inhaled fixed-dose combination powders, and transform nanoparticles into inhalable microparticles. Thus, the importance of spray drying lies not only in optimizing drug delivery efficiency but also in fostering innovation in pulmonary drug delivery of different therapeutics for the treatment of lung and systemic diseases.
This Special Issue aims to highlight current research in formulating inhalable dry powder using spray drying; exploring the complex effect of the processing and formulation factors on the physicochemical and aerosolization properties of the dried powder; the formulation of spray-dried fixed-dose drug combinations for inhalation; understanding the solid-state properties of multicomponent spray dried particles; and utilizing spray drying for formulating inhaled nanoparticles and biopharmaceuticals.
Dr. Nazrul Islam
Dr. Alhajj Nasser
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- spray drying
- processing parameters
- pulmonary drug delivery
- dry powder inhalers
- aerosolization
- drug solubility
- storage stability
- fixed-dose drug combinations
- solid-state properties
- nano-in-microparticles
- biopharmaceuticals
